This page shows the latest Sanofi Pasteur news and features for those working in and with pharma, biotech and healthcare.
Sanofi backs vaccines unit with 350m Canadian facility. The new plant will make paediatric and booster vaccines. ... The move underlines the importance of the Sanofi Pasteur vaccines business to Sanofi even as it suffers a slowdown in growth caused in
Takeda is thought to be furthest ahead in development with TAK-426 - a purified, inactivated, alum-adjuvanted, whole Zika virus vaccine candidate - after Sanofi Pasteur dropped its development programme for another
Sanofi confirms suspected safety issue with dengue vaccine. As rival Takeda conduct phase II testing for its own dengue vaccine candidate. ... Commenting on the new analysis, Su-Peing Ng, global medical head for Sanofi’s vaccine division Sanofi Pasteur,
Will work with the German firm to develop ‘next generation’ cancer vaccines
The new Val de Reuil facility will allow Sanofi Pasteur to increase supply of its new quadrivalent influenza vaccine VaxigripTetra. ... individuals. “As a global leader in flu vaccines, this expansion reinforces Sanofi Pasteur’s ability to tackle
All told, Sanofi reported a 6% increase in sales in the second quarter to 8.66bn, with buoyant growth at Sanofi's rare disease unit Genzyme and vaccines subsidiary Sanofi Pasteur ... Long-acting follow-up Toujeo provided some relief for Sanofi's insulin
More from news
Approximately 13 fully matching, plus 139 partially matching documents found.
In particular the largest deal this month, between MedImmune and Sanofi Pasteur, has a headline figure of $650m, a figure which would have had the deal struggling to get into the ... Headline. $m. AstraZeneca/ MedImmune. Sanofi Pasteur. Joint Development.
Sanofi Pasteur MSD previously required upwards of nine months to bring approved commercial content to market in many of its largest markets. ... Sanofi Pasteur MSD also projects overall efficiency gains of 17% in year one and 33% annually in years two
225. CureVac/ Sanofi Pasteur. Exercise of option, licence. RNActive vaccine technology vs undisclosed pathogens (preclinical).
Scandinavia. CureVac's relationship with Sanofi Pasteur dates back to 2011 when the companies entered into a collaboration and option agreement covering mRNA-based vaccines generated using CureVac's RNActive technology ... Sanofi Pasteur has now
26.6. ‡ SK Chemicals/ Sanofi Pasteur. Collaboration. Pneumococcal conjugate vaccine (PCV). ... Japan . Outside US, Canada. ‡ Sanofi Pasteur has rights outside Korea; SK has exclusive rights for Korea. ‡‡
More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.
Dominique Carouge joins Sanofi as head of business transformation. He also becomes a member of the executive committee. ... for Sanofi Pasteur since 2009.
Meanwhile, Joanna Troman (pictured left) moves to STEM as a project director following 10 years as Sanofi Pasteur MSD in a number of roles across marketing, strategic planning and market research.
Prior to Hill &Knowlton, Marchand served Sanofi, where she worked on French Parliament relations and she has held several positions within the French administration working for general secretariat for European affairs ... In her new role, Marchand will
Tarplee has over 30 years of life science industry experience and previously worked for the likes of Adherium, ALK Abello, Sanofi and Abbott. ... Lim previously worked at Novartis and Sanofi Pasteur, and most recently served at Takeda Pharmaceuticals as
He joins Portland from MHP Communications, where his two-year stint saw him rise to a senior account manager role and included a secondment to Sanofi Pasteur MSD’s comms team.
More from appointments
Approximately 1 fully matching, plus 15 partially matching documents found.
Adam Goodband joins emotive as a Strategic Planner. emotive are pleased to announce the addition of former Sanofi Pasteur MSD medical writer to the team. ... Having experienced working alongside emotive as a medical writer for Sanofi Pasteur MSD, Adam
emotive are pleased to announce the addition of former Sanofi Pasteur MSD medical writer to the team.
Boehringer Ingelheim. GSK. Janssen. Novartis. Pfizer. Sanofi. Sanofi Pasteur MSD. Shire.
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...